Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.448
https://www.valueinhealthjournal.com/article/S1098-3015(13)02353-X/fulltext
Title :
Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02353-X&doi=10.1016/j.jval.2013.08.448
First page :
A400
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
429